Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: out_of_the_loop who wrote (336)	2/19/1999 2:31:00 PM
From: out_of_the_loop	Read Replies (1) \| Respond to of 5582

Today - Press Release by Gel-Tech and CLICK on link to listen to Dr. Hensley being interviewed at newstream.com ***** STREAMING AUDIO: New Technology Leads To Breakthrough In Treatment For The Common Cold (Feb. 19) BUSINESS WIRE - In our fast-paced society we cannot afford to be bogged down with the common cold for weeks. This year alone -- the average adult will get two to four colds, and the average child will get six to eight colds. This will lead to 50-million lost days of work, and 60-million lost days of school. With all the over-the-counter cold remedies available in drugstores, why are people still suffering with colds for so long? Listen to streaming audio which contains comments from Dr. Charles Hensley, Ph.D., chief of Research and Scientific Affairs for Gel Tech, Inc. at newstream.com Keywords: Health Medical Medicine Colds Treatments Remedies Zicam Gel Tech For other online audio and video, please visit newstream.co -0- sw/sa* CONTACT: Medialink, New York Kristin Williams or Marni Klein, 212/682-8300 KEYWORD: NEW YORK CALIFORNIA INDUSTRY KEYWORD: MEDICINE PHARMACEUTICAL Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com :SUBJECT: CPRF HEAL NPRD ENTE MED USA SCI Copyright (c) 1999 Received by NewsEDGE/LAN: 2/19/99 12:42 PM